These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890 [TBL] [Abstract][Full Text] [Related]
3. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice. Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis. Yang JH; Kim KM; Cho SS; Shin SM; Ka SO; Na CS; Park BH; Jegal KH; Kim JK; Ku SK; Lee HJ; Park SG; Cho IJ; Ki SH Antioxid Redox Signal; 2019 Jul; 31(3):243-259. PubMed ID: 30909713 [No Abstract] [Full Text] [Related]
5. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480 [No Abstract] [Full Text] [Related]
6. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells. Jia Y; Wang F; Guo Q; Li M; Wang L; Zhang Z; Jiang S; Jin H; Chen A; Tan S; Zhang F; Shao J; Zheng S Redox Biol; 2018 Oct; 19():375-387. PubMed ID: 30237126 [TBL] [Abstract][Full Text] [Related]
7. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis. Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429 [TBL] [Abstract][Full Text] [Related]
8. Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice. Rampa DR; Feng H; Allur-Subramaniyan S; Shim K; Pekcec A; Lee D; Doods H; Wu D J Transl Med; 2022 Dec; 20(1):590. PubMed ID: 36514072 [TBL] [Abstract][Full Text] [Related]
9. Origin of myofibroblasts in the fibrotic liver in mice. Iwaisako K; Jiang C; Zhang M; Cong M; Moore-Morris TJ; Park TJ; Liu X; Xu J; Wang P; Paik YH; Meng F; Asagiri M; Murray LA; Hofmann AF; Iida T; Glass CK; Brenner DA; Kisseleva T Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3297-305. PubMed ID: 25074909 [TBL] [Abstract][Full Text] [Related]
10. Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis. Zhao G; Hatting M; Nevzorova YA; Peng J; Hu W; Boekschoten MV; Roskams T; Muller M; Gassler N; Liedtke C; Davis RJ; Cubero FJ; Trautwein C Gut; 2014 Jul; 63(7):1159-72. PubMed ID: 24037431 [TBL] [Abstract][Full Text] [Related]
11. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression. Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797 [TBL] [Abstract][Full Text] [Related]
12. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target. She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573 [TBL] [Abstract][Full Text] [Related]
13. JNKs protect from cholestatic liver disease progression by modulating Apelin signalling. Mohamed MR; Haybaeck J; Wu H; Su H; Bartneck M; Lin C; Boekschoten MV; Boor P; Goeppert B; Rupp C; Strnad P; Davis RJ; Cubero FJ; Trautwein C JHEP Rep; 2023 Nov; 5(11):100854. PubMed ID: 37791376 [TBL] [Abstract][Full Text] [Related]
14. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice. Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of dietary capsaicin on liver fibrosis in mice. Bitencourt S; Stradiot L; Verhulst S; Thoen L; Mannaerts I; van Grunsven LA Mol Nutr Food Res; 2015 Jun; 59(6):1107-16. PubMed ID: 25755097 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4. Kim SM; Song GY; Shim A; Lee JH; Eom CB; Liu C; Yang YM; Seki E Exp Mol Med; 2022 Jun; 54(6):739-752. PubMed ID: 35662287 [TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction. Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916 [TBL] [Abstract][Full Text] [Related]